| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement D Moher, L Shamseer, M Clarke, D Ghersi, A Liberati, M Petticrew, ... Systematic reviews 4, 1-9, 2015 | 21594 | 2015 |
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation L Shamseer, D Moher, M Clarke, D Ghersi, A Liberati, M Petticrew, ... Bmj 349, 2015 | 11572 | 2015 |
| ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ... bmj 355, 2016 | 11238 | 2016 |
| Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ... Bmj 348, 2014 | 7523 | 2014 |
| SPIRIT 2013 statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Annals of internal medicine 158 (3), 200-207, 2013 | 5818 | 2013 |
| SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman, H Mann, JA Berlin, ... Bmj 346, 2013 | 4755 | 2013 |
| Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles AW Chan, A Hróbjartsson, MT Haahr, PC Gøtzsche, DG Altman Jama 291 (20), 2457-2465, 2004 | 2101 | 2004 |
| Systematic review of the empirical evidence of study publication bias and outcome reporting bias K Dwan, DG Altman, JA Arnaiz, J Bloom, AW Chan, E Cronin, E Decullier, ... PloS one 3 (8), e3081, 2008 | 1595 | 2008 |
| Biomedical research: increasing value, reducing waste MR Macleod, S Michie, I Roberts, U Dirnagl, I Chalmers, JPA Ioannidis, ... The Lancet 383 (9912), 101-104, 2014 | 1073 | 2014 |
| Systematic review of the empirical evidence of study publication bias and outcome reporting bias—an updated review K Dwan, C Gamble, PR Williamson, JJ Kirkham, Reporting Bias Group PloS one 8 (7), e66844, 2013 | 1049 | 2013 |
| Increasing value and reducing waste: addressing inaccessible research AW Chan, F Song, A Vickers, T Jefferson, K Dickersin, PC Gøtzsche, ... The Lancet 383 (9913), 257-266, 2014 | 895 | 2014 |
| Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension X Liu, SC Rivera, D Moher, MJ Calvert, AK Denniston, H Ashrafian, ... The Lancet Digital Health 2 (10), e537-e548, 2020 | 694 | 2020 |
| Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension M Calvert, D Kyte, R Mercieca-Bebber, A Slade, AW Chan, MT King, ... Jama 319 (5), 483-494, 2018 | 660 | 2018 |
| Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors AW Chan, DG Altman Bmj 330 (7494), 753, 2005 | 657 | 2005 |
| The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed S Hopewell, S Dutton, LM Yu, AW Chan, DG Altman Bmj 340, 2010 | 602 | 2010 |
| Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension SC Rivera, X Liu, AW Chan, AK Denniston, MJ Calvert, H Ashrafian, ... The Lancet Digital Health 2 (10), e549-e560, 2020 | 601 | 2020 |
| Epidemiology and reporting of randomised trials published in PubMed journals AW Chan, DG Altman The Lancet 365 (9465), 1159-1162, 2005 | 582 | 2005 |
| Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research AW Chan, K Krleža-Jerić, I Schmid, DG Altman Cmaj 171 (7), 735-740, 2004 | 534 | 2004 |
| Ghost authorship in industry-initiated randomised trials PC Gøtzsche, A Hróbjartsson, HK Johansen, MT Haahr, DG Altman, ... PLoS medicine 4 (1), e19, 2007 | 386 | 2007 |
| ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355: i4919 JA Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ... | 361 | 2016 |
